Calithera Biosciences Inc. (CALA) News Headlines

▮ More

Date

Headline

1/20/2022 7:39:46 AM Pre-market Movers: STRR, BXRX, CALA, VALN, TKLF…

11/18/2021 7:43:42 AM Pre-market Movers: SEV, VOSO, CALA, ZME, VSCO…

11/1/2021 7:15:36 AM Calithera Presents Interim Data From Phase 1b Trial Of Arginase Inhibitor CB-280 In Cystic Fibrosis

5/17/2021 8:22:34 AM Calithera, Antengene Ink Exclusive Global License Deal For Development Of CB-708 - Quick Facts

1/15/2021 12:11:42 AM FDA Expands Approved Use Of PFE's Xalkori, LXRX Soars On Sotagliflozin Update, BCYC Hits New High

1/5/2021 12:51:44 AM CALA Falls As CANTATA Trial Fails, Haven Healthcare To Be Disbanded, MTNB Awaits MAT9001 Data In Q1

1/4/2021 10:55:32 AM Stock Alert: Calithera Biosciences Tanks 40%

1/4/2021 7:24:17 AM Calithera Biosciences' CANTATA Trial Fails To Achieve Primary Endpoint - Quick Facts

1/4/2021 7:13:06 AM Calithera: CANTATA Study Of Telaglenastat In Renal Cell Carcinoma Did Not Achieve Primary Endpoint

10/5/2017 7:37:55 AM William Blair Initiates Calithera Biosciences Inc. (CALA) At Outperform

1/24/2017 10:01:12 AM Citigroup Ups Calithera Biosciences Inc. (CALA) To neutral From sell With -- Price Target

Older Articles